Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Protean Small Cap's investment thesis on Getinge ($GETI-B.ST) — Q1 2025 | Buyside Digest

All Pitches

View Letter Analysis

$GETI-B.STNASDAQGetinge

BULL

Protean Small Cap—GETI-B.ST

Fund Letter

Q1 2025

Published April 1, 2025

View Fund Profile

$237.70USD

-1.7% vs last month

$194.50Pitched

+22.2% since pitch

Market Cap$64.7B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Despite Getinge dragging on performance in April, the manager believes the market's negative reaction was unwarranted since Q1 earnings met targets. The fund continues...

— Pontus Dackmo

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $GETI-B.ST, and what else Protean Small Cap is buying.

Other pitches on $GETI-B.ST

Other investors who've written on Getinge

No other institutional pitches found for this ticker yet.

View all $GETI-B.ST pitches →